期刊文献+

ATP合成酶β链高表达通过非清道夫受体BI途径增加原代肝细胞对高密度脂蛋白的摄取

Adenovirus mediated over expression of ATP synthase 13-chain increases high-density lipoprotein uptake in primary hepatocytes via non-SR-BI pathway
原文传递
导出
摘要 采用含人C末端标记V5tag的ATPase-B1全长的腺病毒(Ad—ATPase—B1)感染肝细胞株HepG2及清道夫受体BI(SR-BI)敲除小鼠和野生型小鼠原代肝细胞,并观察肝细胞对荧光标记物DiI标记高密度脂蛋白(HDL;DiI—HDL)的摄取情况。Ad—ATPase-B1感染HepG2和原代肝细胞后,可显著上调ATPase.B1mRNA和蛋白水平,且野生型小鼠和SR-BI。原代肝细胞Dil-HDL摄取量均明显升高(P〈0.01)。小鼠肝细胞ATPase-B1可以作为HDL的替代受体,通过非SR-BI途径增加HDL摄取。这可能是一条HDL代谢的新途径.有望作为干预HDL代谢的潜在靶点。 Recombinant adenovirus (Ad) containing the full-length human ATP synthase β-chain ( ATPase- B1 ) tagged with V5 epitope at its C-terminus was constructed and infected to HepG2 cells and primary mouse hepatocytes of wild type and SR-BI knockout mouse. Human plasma high-density lipoprotein (HDL) was prepared and labeled with fluorescent agent DiI ( 1, 1 '-dioctadecyl-3, 3, 3' 3'-tetramethylindocarbocyanine perchlorate ) , and incubated with cultured cells. Cellular uptake of DiI-HDL was counted under a fluorescent microscope. Over expression of mRNA and protein expression of Ad-ATPase-B1 were found in HepG2 cells and primary hepatocytes. The uptake of DiI-HDL was increased in freshly-isolated hepatocytes of both wild type and SR-BI knockout mouse ( P〈0.01 ). ATPase-B1 serves as the receptor for HDL endocytosis via non-SR-BI pathway. ATPase-β1 may represent a potential target for regulation and intervention of HDL metabolism.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第8期705-707,共3页 Chinese Journal of Endocrinology and Metabolism
基金 2010国家自然基金面上项目(81070238)
关键词 ATPase—B1腺病毒 高密度脂蛋白 ATPaseB1 adenovirus High-density lipoprotein
  • 相关文献

参考文献23

  • 1Hausenloy D J, Yellon DM. Targeting residual cardiovascular risk:raising high-density lipoprotein cholesterol levels. Postgrad Med J, 2008,84 : 590-598.
  • 2Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA- I Milano on coronary atherosclerosis in patients with acute coronary syndromes : a randomized controlled trial. JAMA, 2003,290 : 2292- 2300.
  • 3Getz S, Wool D, Reardon A. HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. Curr Pharm Des, 2010,16:3173-3184.
  • 4Rader DJ. Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest, 2006,116 : 3090-3100.
  • 5Kozarsky KF, Donahee MH, Glick JM, et al. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol, 2000,20:721-727.
  • 6Arai T, Wang N, Bezouevski M, et al. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem, 1999,274 : 2366- 2371.
  • 7Ueda Y, Gong E, Royer L, et al. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem, 2000,275:20368-20373.
  • 8Braun A, Zhang S, Miettinen HE, et al. Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. Proc Natl Acad Sci USA, 2003,100:7283-7288.
  • 9Cai L, de Beer MC, de Beer FC, et al. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J Biol Chem, 2005,280:2954- 2961.
  • 10Martinez LO, Jacquet S, Esteve JP, et al. Ectopic beta-chain of ATP synthase is an apolipoproteiu A-I receptor in hepatic HDL endocytosis. Nature, 2003,421:75-79.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部